TCF7L2 Variant rs7903146 Affects the Risk of Type 2 Diabetes by Modulating Incretin Action

TCF7L2 Variant rs7903146 Affects the Risk of Type 2 Diabetes by Modulating Incretin Action Dennis T. Villareal 1 , Heather Robertson 1 , Graeme I. Bell 2 , Bruce W. Patterson 1 , Hung Tran 1 , Burton Wice 1 and Kenneth S. Polonsky 1 1 Department of Medicine, Washington University School of Medicine,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes (New York, N.Y.) N.Y.), 2010-02, Vol.59 (2), p.479-485
Hauptverfasser:	VILLAREAL, Dennis T, ROBERTSON, Heather, BELL, Graeme I, PATTERSON, Bruce W, TRAN, Hung, WICE, Burton, POLONSKY, Kenneth S
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Blood Glucose - metabolism Body Composition C-Peptide - blood Diabetes Diabetes Mellitus, Type 2 - epidemiology Diabetes Mellitus, Type 2 - genetics Diabetes. Impaired glucose tolerance Endocrine pancreas. Apud cells (diseases) Endocrinopathies Etiopathogenesis. Screening. Investigations. Target tissue resistance Female Genetic aspects Genetic Variation Genotype Genotype & phenotype Glucose Glucose Tolerance Test Humans Incretins - physiology Insulin Insulin - metabolism Insulin Secretion Insulin-Secreting Cells - drug effects Insulin-Secreting Cells - metabolism Insulin-Secreting Cells - physiology Male Medical sciences Original Peptide hormones Peptides Physiological aspects Plasma Reference Values Research design Risk Assessment Risk Factors TCF Transcription Factors - genetics Transcription Factor 7-Like 2 Protein Transcription factors Type 2 diabetes
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!